Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Scientists Discovered Genes That Contribute to the ADHD Development

By Sechenov University | October 12, 2018

Design of the study described in the article. Credit: Corominas et al., 2018, supplementary materials

A team from I.M. Sechenov First Moscow State Medical University together with foreign colleagues analyzed the genomes of several families that have members with ADHD. The results have shown that all patients had specific features in certain genes. The identification of such patterns may help diagnose ADHD. The work was published in the Molecular Psychiatryjournal.

ADHD, or attention deficit and hyperactivity disorder, is a common neurodevelopmental disorder with manifestation usually occurring in childhood. According to various sources, this condition affects from 3% to 30% of the population. Children with ADHD are easily distracted, hyperactive and impulsive. ADHD patients may be aggressive and have higher risks for the substance abuse and development of other mental disorders. Only 40% show improvement with age. The pathological mechanisms behind ADHD are still unknown, but scientists prefer the version of joint influence of genetic factors and environmental adversities (e.g., stress or illness of the mother during pregnancy, complications during labor, or diseases suffered in early childhood).

“We believe the development of ADHD may be caused by alterations in the structure of genes encoding proteins which participate in signal transmission in the nervous system using special biologically active substances – neuromediators. In the case of ADHD, the changes affect, among others, serotonin and dopamine pathways in the nervous system that play an important role in the processes of attention, motivation, and learning. The disorder has a complex genetic nature that hasn’t been addressed until recently,” says Evgeniy Svirin, junior research associate of the laboratory of psychiatric neurobiology at I.M. Sechenov First Moscow State Medical University.

The scientists focused on studying the rare functional variants in whole set of genes in several generations of families with running ADHD. They managed to follow the patterns for certain genes, e.g., AAED1. The protein produced by this gene binds with several other proteins that participate in dopaminergic and glutamatergic transmission. Changes in its activity can potentially influence the excitability of some structures of the central nervous system leading to behavioral alterations. Moreover, to the association with ADHD was discovered for another gene with an unknown function – ATAD2. Notably, these rare variants were also found in ADHD patients outside the studied families. These findings give further evidence for considering them as ADHD risk genes.

“We have discovered new rare functional variants associated with the risk of ADHD development. Our results may be of use for the development of genetic diagnostics methods for this complex disorder. Further studies of the rare AAED1 gene variant on brain development that are already carried out by our joint team with German researchers, may help better understand pathological mechanisms that lead to the occurrence of this disease,” concludes Evgeniy Svirin.


Filed Under: Neurological Disease

 

Related Articles Read More >

Novo Nordisk in the Drug Discovery & Development Pharma 50
Novo Alzheimer’s trial disappoints as amycretin shines
Shifting mindsets all around: clinical thinking about Alzheimer’s disease moves from symptoms treatment toward earlier intervention and prevention
Quanterix VP: Why biomarkers are no longer supplemental
Texas sues Kenvue claiming it hid link between Tylenol and autism
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE